Dr. Corrie Vanexel Alford, MD

Dr. Alford practices at Metroderm in Atlanta, Georgia.

Dr. Alford's NPI, 1891701496, was assigned on August 1, 2006. Dr. Alford graduated from Emory School of Medicine in 2002. Dr. Alford's Georgia license number on file is 57567.

Dr. Alford's primary practice is Metroderm, at 875 Johnson Ferry NE Rd, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 257-9933.

Dr. Alford's primary practice is Metroderm in Atlanta, Georgia. The medical group on file is MetroDerm. Dmand AI also links Dr. Alford to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alford practices. Vendor and product names are available with a free account.

Dermatology is Dr. Alford's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Alford is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Alford's licenses on file in 2 states: Georgia and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Alford treats.

CMS data shows 2,918 Medicare services from Dr. Alford across 16 procedure codes in 2024, for 938 Medicare patients. Medicare paid $150,527 for them. Every service was in an office.

CMS counts 938 Medicare patients who saw Dr. Alford in 2024. The largest group is 65 to 74, with 449 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alford's median patient age at 63, with 68% women.

In 2024, Dr. Alford wrote 1,048 Medicare Part D claims for 395 patients. 91% of them were for generic drugs. CMS names the drug for 834 of them, across 26 drugs with 11 or more claims each, at $127,480 in total drug cost. In 2023, CMS named 816 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Alford for performance year 2024, reported through an alternative payment model (APM). Dr. Alford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 327 procedures of skin biopsy by Dr. Alford, more than 91% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 794 general payments to Dr. Alford from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $2,609.

Dmand AI lists 1 award for Dr. Alford.

Dr. Alford graduated from Emory School of Medicine in 2002. Dr. Alford is a member of AAD.

Dr. Alford is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.